Challenge
Rapid market adoption of breast imaging technology by healthcare providers was critical to revolutionize cancer screening in dense breast tissue and improve patient outcomes.
Solution
To achieve early market success, the company partnered with S2N Health to target high-value prospects and effectively demonstrate the value proposition of the new technology to potential customers.
- Leveraging Data For Targeted Outreach: S2N Health deployed RepSignal, providing the company with detailed insights into key accounts and physicians to prioritize high-value targets most likely to benefit from their new technology.
- Seamless CRM Integration: RepSignal was seamlessly integrated with their Salesforce CRM. This emersion ensured that sales and marketing teams had access to the most up-to-date customer information and insights within existing workflows.
- Pre-Populating Sales Opportunities: S2N Health introduced over 500 high-value sales opportunities, provided clear recommendations on how to pursue the most promising leads, and guidance on playbook development for referral ecosystems.
Immediately, we've been looking at our strategy in a different way.
We have a clear vision of who we need to target and how.
We have a clear vision of who we need to target and how.
—Mark Edwards, Director of Commercial Operations, Delphinus
Impact
This case study demonstrates the power of data-driven sales and marketing strategies and accelerating the adoption of innovative medical technologies. By partnering with S2N Health, Delphinus was able to supercharge early market success, increase focus and productivity, and improve customer engagement.
